Glassman Wealth Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,640
| Closed | -$214K | – | 832 |
|
|
2023
Q4 | $214K | Buy |
2,640
+126
| +5% | +$9.8K | 0.03% | 178 |
|
|
2023
Q3 | $188K | Buy |
2,514
+2
| +0.1% | +$154 | 0.03% | 179 |
|
|
2023
Q2 | $194K | Sell |
2,512
-52
| -2% | -$4.15K | 0.03% | 175 |
|
|
2023
Q1 | $213K | Buy |
2,564
+19
| +0.7% | +$1.57K | 0.04% | 160 |
|
|
2022
Q4 | $219K | Buy |
2,545
+208
| +9% | +$16.5K | 0.04% | 163 |
|
|
2022
Q3 | $144K | Buy |
2,337
+231
| +11% | +$14.6K | 0.03% | 192 |
|
|
2022
Q2 | $130K | Buy |
2,106
+315
| +18% | +$19.5K | 0.03% | 208 |
|
|
2022
Q1 | $106K | Buy |
1,791
+132
| +8% | +$8.44K | 0.02% | 250 |
|
|
2021
Q4 | $120K | Buy |
1,659
+20
| +1% | +$1.38K | 0.02% | 217 |
|
|
2021
Q3 | $114K | Buy |
1,639
+464
| +39% | +$32.6K | 0.02% | 222 |
|
|
2021
Q2 | $81K | Buy |
1,175
+4
| +0.3% | +$267 | 0.02% | 267 |
|
|
2021
Q1 | $76K | Buy |
1,171
+80
| +7% | +$5.16K | 0.02% | 265 |
|
|
2020
Q4 | $64K | Buy |
1,091
+93
| +9% | +$5.61K | 0.01% | 299 |
|
|
2020
Q3 | $63K | Sell |
998
-339
| -25% | -$23.5K | 0.02% | 261 |
|
|
2020
Q2 | $103K | Buy |
1,337
+2
| +0.1% | +$153 | 0.03% | 170 |
|
|
2020
Q1 | $100K | Buy |
1,335
+217
| +19% | +$15K | 0.04% | 161 |
|
|
2019
Q4 | $73K | Buy |
1,118
+32
| +3% | +$2.08K | 0.03% | 209 |
|
|
2019
Q3 | $69K | Buy |
1,086
+5
| +0.5% | +$327 | 0.03% | 201 |
|
|
2019
Q2 | $73K | Buy |
1,081
+50
| +5% | +$3.29K | 0.03% | 198 |
|
|
2019
Q1 | $67K | Buy |
1,031
+257
| +33% | +$17.1K | 0.03% | 202 |
|
|
2018
Q4 | $48K | Sell |
774
-6
| -0.8% | -$419 | 0.03% | 197 |
|
|
2018
Q3 | $60K | Sell |
780
-180
| -19% | -$13.6K | 0.03% | 197 |
|
|
2018
Q2 | $68K | Buy |
960
+510
| +113% | +$36K | 0.03% | 164 |
|
|
2018
Q1 | $34K | Hold |
450
| – | – | 0.02% | 217 |
|
|
2017
Q4 | $32K | Buy |
450
+33
| +8% | +$2.51K | 0.02% | 198 |
|
|
2017
Q3 | $34K | Hold |
417
| – | – | 0.02% | 178 |
|
|
2017
Q2 | $30K | Sell |
417
-861
| -67% | -$57.3K | 0.02% | 194 |
|
|
2017
Q1 | $87K | Buy |
1,278
+615
| +93% | +$43.2K | 0.06% | 125 |
|
|
2016
Q4 | $47K | Buy |
663
+251
| +61% | +$18.7K | 0.03% | 179 |
|
|
2016
Q3 | $33K | Sell |
412
-70
| -15% | -$5.69K | 0.03% | 178 |
|
|
2016
Q2 | $40K | Hold |
482
| – | – | 0.03% | 154 |
|
|
2016
Q1 | $44K | Hold |
482
| – | – | 0.04% | 145 |
|
|
2015
Q4 | $49K | Hold |
482
| – | – | 0.04% | 142 |
|
|
2015
Q3 | $47K | Hold |
482
| – | – | 0.04% | 145 |
|
|
2015
Q2 | $56K | Hold |
482
| – | – | 0.05% | 142 |
|
|
2015
Q1 | $47K | Buy |
482
+145
| +43% | +$14.7K | 0.04% | 153 |
|
|
2014
Q4 | $32K | Buy |
+337
| New | +$34.9K | 0.02% | 188 |
|
Other funds holding GILD
Glassman Wealth Services's GILD Position: Q1 2024 in Review
Glassman Wealth Services sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 2,640 shares — an estimated $214K sold.
Glassman Wealth Services first reported a position in GILD in Q4 2014 and held it in 37 quarters. The position peaked at $219K in Q4 2022. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Glassman Wealth Services reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 2,640 Gilead Sciences shares in Q1 2024, an estimated $214K.
- Glassman Wealth Services first reported a position in Gilead Sciences in Q4 2014 and held it in 37 quarters.
- Glassman Wealth Services's Gilead Sciences position peaked at $219K in Q4 2022.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.